Study of JNP-0101 for the delivery of nine amino acid peptide leuprolide.
Phase of Trial: Phase I
Latest Information Update: 26 Aug 2016
At a glance
- Drugs Leuprorelin (Primary)
- Indications Unspecified
- Focus Adverse reactions; Pharmacodynamics; Pharmacokinetics; Proof of concept
- 26 Aug 2016 New trial record
- 04 Aug 2016 According to a Juniper Pharmaceuticals media release, data from this study is published in Journal of Controlled Release.